Science Explorer Back to mapMap
Discussion
Researcher · Institut Curie · France

Delphine Loirat

Delphine Loirat publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#131,873
of 7,710,434 ranked researchers
Rank in France
#9,745
of 324,115
Works
211
Citations
7.9k
Citations per work
37.4
h-index
40
i10-index 85Top 6.3% in Oncology
Delphine Loirat

What does Delphine Loirat research?

Delphine Loirat's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (6%).

Health Sciences: 126 works · 59.6% of their workMedicine: 126 works · 59.6% of their workOncology: 77 works · 36.6% of their workPulmonary and Respiratory Medicine: 36 works · 17.0% of their workRadiology, Nuclear Medicine and Imaging: 13 works · 6.0% of their workLife Sciences: 43 works · 20.2% of their workBiochemistry, Genetics and Molecular Biology: 29 works · 13.7% of their workCancer Research: 23 works · 11.0% of their workMolecular Biology: 6 works · 2.7% of their workImmunology and Microbiology: 14 works · 6.5% of their workImmunology: 14 works · 6.5% of their workEverything else: 43 works · 20.2% of their workTHEIR WORKDelphine Loirat211works
Life Sciences20%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12659.6%
    1. Biochemistry, Genetics and Molecular Biology2913.7%
    2. Immunology and Microbiology146.5%
  3. Everything else4320.2%
  1. 1Oncology37% of their works
  2. 2Pulmonary and Respiratory Medicine17% of their works
  3. 3Cancer Research11% of their works
  4. 4Immunology6% of their works
  5. 5Radiology, Nuclear Medicine and Imaging6% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Delphine Loirat's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, HER2, Trastuzumab, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Breast Cancer1212 topics
  2. Metastatic Breast Cancer1052 topics
  3. CDK4/6 Inhibitors691 topic
  4. Palbociclib691 topic
  5. HER2521 topic
  6. Trastuzumab521 topic
  7. Immune Checkpoint Blockade461 topic
  8. PD-1 and PD-L1461 topic
  9. Breast Tumours401 topic
  10. Gene Expression401 topic
  11. Targeted Therapy382 topics
  12. Chemotherapy-Induced Peripheral Neuropathy361 topic
  13. Taxanes361 topic
  14. Cancer Genomics201 topic
  15. Mutational Signatures201 topic
  16. Dendritic Cells191 topic
  17. Immunity191 topic
  18. PET Imaging181 topic
  19. Radiopharmaceuticals181 topic

Where does Delphine Loirat work?

Delphine Loirat's main affiliation in the publication record is Institut Curie, France.

How many publications and citations does Delphine Loirat have?

OpenAlex counts 211 works and 7,883 citations for Delphine Loirat, an h-index of 40, ranking #131,873 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Delphine Loirat

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Delphine Loirat. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.